Cargando…
Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening
The limited success of recent phenotypic anti-leishmanial drug screening campaigns calls for new screening strategies for the discovery of clinically relevant hits. Here we present such a novel strategy based on physiologically relevant, ex vivo biology. We established high content phenotypic assays...
Autores principales: | Lamotte, S., Aulner, N., Späth, G. F., Prina, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345745/ https://www.ncbi.nlm.nih.gov/pubmed/30679614 http://dx.doi.org/10.1038/s41598-018-36944-6 |
Ejemplares similares
-
Author Correction: Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening
por: Lamotte, S., et al.
Publicado: (2019) -
High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery
por: Aulner, Nathalie, et al.
Publicado: (2013) -
High Content Analysis of Macrophage-Targeting EhPIb-Compounds against Cutaneous and Visceral Leishmania Species
por: Fehling, Helena, et al.
Publicado: (2021) -
The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery
por: Lamotte, Suzanne, et al.
Publicado: (2017) -
Visceral leishmaniasis with cutaneous involvement caused by Leishmania infantum-chagasi
por: Raja, Mohammed, et al.
Publicado: (2017)